Atherosclerosis of cerebral arteries in Alzheimer disease

Stroke

Volumn 35, Issue 11 SUPPL. 1, 2004, Pages 2623-2627

  Roher, Alex E ^a   Esh, Chera ^a   Rahman, Afroza ^a   Kokjohn, Tyler A ^b   Beach, Thomas G ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Atherosclerosis; Cerebral ischemia; Circle of Willis

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTERY OCCLUSION; ATHEROSCLEROSIS; BRAIN ARTERY; BRAIN CIRCULUS ARTERIOSUS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CIRCLE OF WILLIS; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MENINGES;

EID: 7644223663     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000143317.70478.b3     Document Type: Conference Paper

References (12)

1. de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002;33:1152-1162.
2. Kalaria RN. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc Dis. 2002;13:48-52.
3. Iadecola C, Gorelick PB. Converging pathologic mechanisms in vascular and neurodegenerative dementia. Stroke. 2003;34:335-337.
4. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, Sue LI, Beach TG. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol. 2003;23:2055-2062.
5. Kalback W, Esh C, Castano EM, Rahman A, Kokjohn T, Luehrs DC, Sue L, Cisneros R, Borhman B, Beach TG, Roher AE. On the vascular pathogenesis of sporadic Alzheimer's disease. Neurological Res. 2004;26:525-539.
6. Mirra SS. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol Aging. 1997;18:S91-S94.
7. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging. 1997;18:S1-S2.
8. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545-548.
9. Braak H, Braak E. Staging of Alzheimer-related cortical destruction. Int Psychogeriatr. 1997;9:257-272.
10. Roher AE, Kuo YM, Esh C, Knebel C, Weiss N, Kalback W, Luehrs DC, Childress JL, Beach TG, Weller RO, Kokjohn TA. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med. 2003;9:112-122.
11. Harris MB, Blackstone MA, Sood SG, Li C, Goolsby JM, Venema VJ, Kemp BE, Venema RC. Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. Am J Physiol Heart Circ Physiol 2004;287:H560-H566.
12. Sparks DL, Connor D, Lopez J, Launer L, Petanceska S, Baxter L, Wasser D, Lochhead J, Ziolowski C, Idouraine A, Browne P, Sabbagh M. Benefit of atorvastatin in the treatment of Alzheimer disease. Neurobiol Aging. 2004;25:S24. Abstract 86.